摘要:
The invention relates to a polypeptide which comprises the fragment SEQ ID No.: 2 of the peptide GSE 24.2 (SEQ ID No.:1) and can reduce the production of free radicals and/or damage to the DNA structure of a cell, optionally comprising nuclear localisation sequences. The invention also relates to a polynucleotide and to a vector, which comprise sequences coding for said polypeptide, and to a pharmaceutical composition comprising said polypeptide, polynucleotide and/or vector. The invention further relates to the applications of the polypeptide, such as the use thereof for treating and/or preventing diseases caused by an increase in oxidative stress and/or damage to cellular DNA, such as ataxia-telangiectasia or dyskeratosis congenita, or the use thereof in tissue engineering and cell culture for increasing the viability of same.
摘要翻译:本发明涉及包含肽GSE 24.2(SEQ ID No.1)的SEQ ID No.2的片段的多肽,并且可以任选地减少游离基的产生和/或细胞的DNA结构的损伤 包括核定位序列。 本发明还涉及包含编码所述多肽的序列的多核苷酸和载体,以及包含所述多肽,多核苷酸和/或载体的药物组合物。 本发明还涉及多肽的应用,例如其用于治疗和/或预防由氧化应激增加和/或细胞DNA损伤引起的疾病,例如共济失调 - 毛细血管扩张症或先天性角化不全,或使用 在组织工程和细胞培养中增加其生存能力。
摘要:
The invention relates to a polypeptide which comprises the fragment SEQ ID No.: 2 of the peptide GSE 24.2 (SEQ ID No.:1) and can reduce the production of free radicals and/or damage to the DNA structure of a cell, optionally comprising nuclear localisation sequences. The invention also relates to a polynucleotide and to a vector, which comprise sequences coding for said polypeptide, and to a pharmaceutical composition comprising said polypeptide, polynucleotide and/or vector. The invention further relates to the applications of the polypeptide, such as the use thereof for treating and/or preventing diseases caused by an increase in oxidative stress and/or damage to cellular DNA, such as ataxia-telangiectasia or dyskeratosis congenita, or the use thereof in tissue engineering and cell culture for increasing the viability of same.